COVID 19 and cancer services - Business as Usual?

By Dr Stephen Falk, Consultant Oncologist

Posted 10 December 2021

3 Minute Read

cancer-patient-during-covid19-INNEG

Tags:

  • COVID-19
  • Delayed Cancer Diagnosis
  • Oncology Expert Witness
  • Cancer Treatment Backlog
  • Remote Consultation Litigation
  • Oncology Negligence

Expert Disciplines:

  • Oncology

About The Author

Dr Stephen Falk

Dr Stephen Falk

Consultant Oncologist

Dr Stephen Falk is a Consultant Oncologist with extensive experience in medico-legal reporting. He qualified from Liverpool University in 1983 and completed oncology training in Cardiff and Cambridge before his consultant appointment in Bristol in 1994. He also holds sessional commitments at Southmead Hospital, Bristol. His specialist interests include gastrointestinal cancers (oesophagus, stomach, pancreas, colorectal, hepatobiliary), lung cancer, lymphomas, skin cancers, radiotherapy, and chemotherapy. Dr Falk is an experienced expert witness.

From the Blog

Related Articles

covid-doctors-gp-practice
Blog8 min read

Explore expert insights on how remote GP consultations impact diagnosis, patient care, and negligence risks - vital knowledge to navigate claims and strengthen your clinical negligence cases.

cervical-cancer-litigation-screening
Blog5 min read

Gain expert insight into where and why cervical screening errors occur, strengthening your ability to assess, argue, and advise on potential claims.

covid-vaccine-INNEG-small-bottle
Blog6 min read

Explore key legal risks around consent, documentation, and vaccine errors - vital insight for clinical negligence claims arising from COVID-19 vaccine administration.

Request a callback, or contact us.

Thank you for your request!

We will get back to you as soon as possible.

COVID-19’s Impact on Cancer: Challenges & Litigation Risks